ç 究è ï¼ãã¹ãã¯ï¼ã®çµ¦æã»å¹´åè£è¶³ ãã¹ãã¯ã¨å¼ã°ããç 究è ã®å¹³åå¹´åã¯300ä¸åç¨åº¦ã¨ããã»ã©é«ãã¯ãªããé«ã人ã§ã500ä¸åï½600ä¸åç¨åº¦ã§ãã ä¸è¬ä¼æ¥ã«å¤ããä¼ç¤¾å¡ã®æ¹ã給æãããã£ã¦ããã¨èãã¦ããã§ãããã ç¹ã«20代ã30代ã¨ãã£ãè¥ãä¸ä»£ã®å ´åãå¹´å200ä¸åå°ã¨ããã®ãçããããã¾ããã ããã«å¥åº·ä¿éºãéå¤æå½ãªã©ããªãã±ã¼ã¹ããããæ給ã¯30代ã§25ä¸ååå¾ã ã¨èããæ¹ãããã§ãããã ç 究è ï¼ãã¹ãã¯ï¼ã®ä»äºå 容 ãã¹ãã¯ã¨ã¯å士å·ãåå¾å¾ã2å¹´ï½3å¹´ã®æééå®ã§ç 究è ã¨ãã¦åã人ã®ãã¨ãããã¾ãã å士ç 究å¡ã¨ãããããå士å·ãåå¾ãã人ã®ç´3å²ï½4å²ã»ã©ããã¹ãã¯ã¨ãã¦åãã¦ãã¾ãã 主ãªä»äºã¯å¤§å¦ãç 究æ©é¢ã§ã®ç 究ã§ããã¼ãã¯äººã«ãã£ã¦ç°ãªãã¾ãã èªåãç 究ããããã¼ããè¨å®ã§ããå ´åãããã¾ããã大å¦ã®ææã®ãã¨ã§åãå ´åã¯ææã®ç 究ãã¼ããèªèº«ã®ç 究ã
å¤å·£ã®ç 究æã®ã©ãã®å¾è¼©ã¨ã¹ã«ã¤ããããã話ãèããã è¿æã®ã©ãã®é¢çãNãã¯ããè¤æ°è«æãåºããï¼ããã¼ãã¼ãã§ã¯é¢çãCNSãåºãã®ã¯æ¬å½ã«ã«ã³ã¿ã³ï¼ãã¹æ¯ããã¯ããã«ã©ã¯ï¼ãããåæ¥ã¨ããæã«ãPIããã¹ããããããã£ããPIãã¯ããããã¯ãåã«è«æããã¬ã¼ã³ãããããåã®åã§ãä½ã§ããªããããã¾ã§ã¯ç´å¾ã ãã©ããããããããããããã¨3æ¬è«æãåºãã¾ã§ã¯åæ¥ãããªãããªããªããåãã使ãã人æãããªãããããã¡ãã£ã¨æå³ä¸æãé¢çã«å®åãªãã¨è¨ã£ã¦ãããªãããä»ã«ã¾ã¨ããªã®ãããªãã¨ãã件ã®é¢çã¯ãµã¤ã¨ã³ã¹ãè¾ããããããªãã¨ãã¹ã®æ¨è¦ç¶ãã¯ã½ã«ãªãã®ã§ããã¹ãã¯å æ¢ãããå³ãããã¢ã¡ãªã«ã¯æ¨è¦ç¶å¤©å½ï¼å°çï¼ï¼ãªã®ã§ããããæªãæå³ã§æ ¹åããããã¨ã§ç¥ããã¦ãPIã ããå½¼ãæ°å¹´åã¯ãããã¯ãã¹ãå°æ¬ãããã¨ãè¨ã£ã¦ãã®ã«ã ãã©ãã¯ã©ãã¨ãã¦æåãªã¨ããªã®ã§ãããããã¨ãã½ã¼ãã«
å¦è¡ç 究åéã§ã®ç«¶äºã¯æ¿åãã¦ãããç 究è ã¯æ§ã ãªå´é¢âè³éæºã®æ§é ãåºçå½¢å¼ããã£ãªã¢ã®å±æãç 究管çã·ã¹ãã âããå½±é¿ãåãã¦ãã¾ããå¦è¡çã§ç¬ãç«ã¡ããä¸æ©æåã®ããã£ãªã¢ä¸ã®éè¦å±é¢ã«ä½ç½®ãããã¹ãã¯ç 究è ã¯ãç§å¦ç 究ã«ãããæåçå½±é¿ããã£ã¨ãå¼·ãåãã¦ããã¨ããã¾ãããã¹ãã¯ç 究è ã¯ãå¤ãã®æ©é¢ã§ç 究ãç½å¼ããç«å ´ã«ãããå¦è¡ç 究ã®æªæ¥ãæ ã£ã¦ãã¾ãããããæ¿ãã競äºä¸ã«ç½®ãããå®å®ããè·ã®ç¢ºä¿ãé£ããã¨ããå½¼ãã®ç´é¢ããåé¡ã¯ããã¾ãåãä¸ãããããã¨ãããã¾ããããããªä¸ãç±³å½ã¨è±å½ã®ãã¹ãã¯ãç´é¢ãã¦ããåé¡ã¨ç¾ç¶ãåãä¸ãã2ã¤ã®å ±åæ¸ããäºæ ãéãè¦ã¦ããå¦è ãã¡ã®æ³¨ç®ãéãã¦ãã¾ãã以ä¸ã¯ããã®2ã¤ã®å ±åæ¸ã§æãããã¦ãã主ãªåé¡ç¹ã§ãã è±å½ã®ã¬ãã¼ãâè±å½ã«ãããç§å¦ç 究æå Nuffield Council on Bioethicsãã¾ã¨ãããã®ã¬ãã¼ãã§ã¯ã
ã大å¦ã®äºç®åæ¸ã§ãã¹ãã失ã£ãï¼ï¼æ³ã®çç©ç³»ç 究è ãå½¼ã次ã®ç¨¼æ¥ã¨ãã¦é¸ãã ã®ã¯ãå ã¢ã«ããã¢ã®ã¡ã³ãã¼ãéããããã¾ã§ã®ç¥èãçãããå±éºãã©ãã°ãä½ã£ã¦å£²ããã°ããã¨ã ã£ãâ¥ãã ããã¯ãã¤ã¿ãªã¢æ ç»ç¥2015ã§ä¸æ ãããæ ç»ããã¤ã ã£ã¦ããããããã®ã¹ãã¼ãªã¼ã§ããåä½åã¯ã¤ã¿ãªã¢ã®ã´ã¼ã«ãã³ã»ã°ãã¼ãè³ã§æåªç§ã³ã¡ãã£ã¼è³ãåè³ãããããªã ç 究è ããã¯ã¹ãªã®å£²äººã«ãæµ·å¤ã®ãã£ã¯ã·ã§ã³ã§ããããããæ¥æ¬ã®è¥æç 究è ã®ãã¨ãããããã®ä¸äººã§ããèªåã®ãå°æ¥åã«ãªããªãã¦ãã¨ãããã§ãããã!? ãããªãã¨ãããããªãããããã¨èªåã«è¨ãèãããªãããæ¥æ¬ã®ãã¥ã¼ã¹ãè¦ãã¨ããå士å·ã®åå¾è ã5å¹´ã§åã«ããããã人æç³»å¦é¨ã»å¤§å¦é¢ãè¦æ¨¡ç¸®å°ã¸è»¢æããªã©ãä½ãããè¦ããè¥æãããã«å¢ããã¦ãã¾ããããªæ¿çæ¡ã次ã ã¨åºã¦ãã¦ãã¾ãããããããããªãã¨ããæå¤ã¨ãããããããªã!? æç§ç
There is a growing number of postdocs and few places in academia for them to go. But change could be on the way. By the time Sophie Thuault-Restituito reached her twelfth year as a postdoctoral fellow, she had finally had enough. She had completed her first postdoc in London, then moved to New York University (NYU) in 2004 to start a second. Eight years and two laboratories later, she was still th
Yachie Laboratory School of Biomedical Engineering (SBME) The University of British Columbia (UBC) Biomedical Research Centre 2222 Health Sciences Mall Vancouver, BC Canada V6T 1Z3 Yachie Laboratory Premium Research Institute for Human Metaverse Medicine (PRIMe) Osaka University The Center of Medical Innovation and Translational Research 2-2, Yamadaoka Suita, Osaka, Japan 565-0871 è°·å æ±ç 究室 大éªå¤§å¦ãã¥ã¼ãã³
ãããç 究è ãã¡ã¯ããããã©ããªã£ã¡ããã®ã§ããããï¼ãã話é¡ã«ãªãããã¾ãããèããã質åã§ãã ããããã¯çç©ç³»ã¨ãããçå½ç§å¦ç³»ã®äººéãªã®ã§ç©çãåå¦ãªã©ã®è¥ãç 究è ã®å°æ¥ã¯æ¥æ¬ã§ã©ããªã£ã¦ããã®ããããã¾ããã çå½ç³»ã§ã¯ãã¾ãããã°ããå°æ¥ãèããã®ã¯æ£ç´é£ããã§ãããã ç 究è ã¯ã ãã ã£ã¦å¥½ããã®ãã§èçãªç«¶äºã«ãããããããªç°å¢ã好ãã¯ããããã¾ããã ã ãããè½ã¡çãã¦ããããç 究ããããã¨é¡ããã®ã§ãããããï¼å¹´ãããã¦ãï¼å¹´ã§è·ãç¡ããªãã次ãã¿ã¤ãããã©ããåãããªãã£ããä¸å®ã ãæ¯æ¥ã楽ããã¯ããããã¾ããã ããããåéã«ã©ããã¦ãè¡ãããã¨é¡ãè¥è ãæ¸ãã®ã¯å½ç¶ã§ãããã ãã£ãããªãã©ããã¦ãã®ãããªãã¬ã³ãï¼æµãï¼ã®ç 究社ä¼ç°å¢ã«ãªã£ãã®ã§ããããã誰ããæå³ãã¦è¨ç»ããããã§ãªããããããå¥å ¨ãªç«¶äºã®ãã¨ã«ãããçå½ç§å¦ã®çºå±ããä¼å³ãã¦ç 究è ã¤ã¾ãå¦ä½å
æ¿åºã¯ãå士å·åå¾å¾ãå©æãªã©ã®ãã¹ãã«å°±ããç 究ããã¦ããããã¹ããã¯ã¿ã¼ï¼ãã¹ãã¯ï¼ãããæ£è¦ã®è·ã«å°±ããããå½ç«å¤§ã«ä¿ãæ¹éã ã å®å®ããè·ãå¾ãããªãç 究è ãå¢ããã°ãç 究éçºã®åºç¤ãæºãããããªãããã ãããã¹ãã¯å¯¾çãã®å®ç¸¾ã«å¿ãã大å¦ã«é ãäºç®ï¼éå¶è²»äº¤ä»éï¼ã«å·®ãã¤ãã対çã®å¹æãé«ããèãã ã 財åçã¨æé¨ç§å¦çã調æ´ããï¼æä¸æ¬ã«ã¾ã¨ããæ¿åºã®ã骨太ã®æ¹éï¼çµæ¸è²¡æ¿éå¶ã®åºæ¬æ¹éï¼ãã«åæ ãããï¼ï¼ï¼ï¼å¹´åº¦ã«ãå®æ½ãããæåã ããã¹ãã¯ãå¦å å¤ã§æ£è¦ã®ç 究è·ã«å°±ããããã«ãããããå½ç«å¤§ã«ãï¼ãå¦å ã§è¥æåãã®ãã¹ããå¢ãããï¼ãç£å¦é£æºãå¼·åããä¼æ¥ãå«ãå®å®ããè·ã«å°±ããããã«ããââãã¨ãªã©ãæ±ãããå½ç«å¤§ã®éå¶è²»äº¤ä»éï¼ç´ï¼ã»ï¼å åï¼ã®é åã硬ç´åãã¦ããã¨ã®å£°ããããã対çãã®ææãè¸ã¾ãé åãè¦ç´ãæ¹åã ã 大å¦é¢çã¯ï¼ï¼ï¼ï¼å¹´åº¦ã®ï¼ä¸ï¼ï¼ï¼ï¼äººãï¼ï¼
I have enjoyed research and teaching for the last twelve years. Yet, I have resigned from my postdoctoral position at MIT a week ago, giving up on the dream of an academic position. I feel liberated and happy, and this is a very bad sign for the future of life sciences in the United States. Michael Eisen, my co-advisor from graduate school at Berkeley recently wrote that it is a great time to do s
ç 究è ãã£ã¦ã¾ãã æµãçãã¦ç°èã«ãã¾ããã ãªãã¨ããã¼ããã³ãã¯ã²ãããããã©ãç 究ãããæè²ã§ããï¼ã¿ãããªä¸»å¼µãå¹ ããããã¦ããã ç 究費ãã»ã¨ãã©ãªããããªã¨ããã ã£ãã å®å®ãããã¸ã·ã§ã³ã§ããã£ããç 究ãã¦ãã¿ãããªçæ´»ã«æ§ãã¦ããã©ããªãããããä¸çç¶ããã ãªã¨ æãã¨ãã£ããææãè¦ãã¦ããã ããã£ã¦ç 究è ã®ãã¸ã·ã§ã³ãªãã ãããã ç 究ãã§ãããã¸ã·ã§ã³ãªã ããªæ°ãããã ã§ããã°æ é·ã«å¸°ãããã ãããªãªãã®ãããããªãç°èã§å¹´ãã¨ã£ã¦ããã®ã¯ãããã ã§ãããã¾ã®ç 究è ã®ç¾ç¶ãèããã¨ãããã§ã幸ããªãã ããªãã¨ãæãã ãã¹ãã¯ã«æ»ã£ãã£ã¦ãã©ããªãããã§ããªãã ããã ãã¹ãã¯ã«æ»ãã°ãæ¶ãåºãã»ã©ãã¼ããã³ãã«æ§ãããã ãããã ãããã©ãããããããªãç¡ãç©ãã ããªã®ããªã
ãã¹ãã¯ã«æ±ããããæ¥ç¸¾ã®ã¤ã³ãã¬ã¼ã·ã§ã³åã¨40代å©æã»åææã®æ¥ç¸¾ã®é³è ãã®ã¢ã³ãã©ã³ã¹ã«ã¤ã㦠ç§ã¯æ¥æ¬ã§ãã¹ãã¯ããã¦ãã¾ããå°æ¥ã¯æ¥æ¬ãããã¯ã¢ã¡ãªã«ã§èªåã®ã©ããæã¡ããã¨æã£ã¦ãã¾ãããããããã¤ãªç³»ã®ç 究è ã®ããã空ãã¦ãããã¹ãã¯ã»ã¨ãã©ãªãã«ãé¢ããã競äºç¸æãé常ã«å¤ããä»å¾ã©ãããã¹ããã¨éæ¹ã«æ®ãã¦ãã¾ããã¨ãããã¾ãã ååãè¯ãé¢åãè¦ã¦ããã£ã¦ããå¹´é ã®å çæ¹ã¨è©±ãããã¨ããã¹ãã¯ãåæ¥ããããã®æ¥ç¸¾ã®æä½ã©ã¤ã³ãããæ°å¹´ã§é©ãã»ã©ä¸æãã¦ããã¨ãããã¨ãå®æããããã¾ãã ä»ããã¹ãã¯ãåæ¥ããã«ã¯ãNature/Cell/Scienceã«çé èè ã®è«æãæã£ã¦ããã®ã¯å½ç¶ã§ããããéèªã®å§å¦¹ç´ã§ããã°ä¸ã¤ã ãã§ã¯è¶³ããªãã¨ã¾ã§è¨ããããã¨ãããã¾ãã ããã«ã¢ã¡ãªã«ã§ã©ããæã¨ãã¨ããã¨ããããã£ãæ¥ç¸¾ã«å ãã¦å¤§å¾¡æç 究è ãã¡ã¨ã®ã³ãï¼ããããç 究è éã®
å¦æ¯ PD ãä»»æ 4 å¹´éã«ãªãã ã¨ããå½ç«å¤§å¦æå¡ã®çµ¦æã年俸å¶ã«ç§»è¡ããã ã¨ãã¨ãããã¥ã¼ã¹ãç®ã«ãã¦ãåã ããæ°ã«ãªã£ã¦ãããã¹ãã¯ã®çµ¦æã®ç¸å ´ãã©ããªãã®ã調ã¹ã¦ã¿ã¾ããã å士å·ã ãã§ã¯ä¸åå! âçç³»ç 究è ã¨ãã¦çãæ®ãããã« ä½è : ãã¼ã¿ã¼ã»Jã»ãã¡ã¤ãã«ãã³,西尾義人åºç社/ã¡ã¼ã«ã¼: ç½æ社çºå£²æ¥: 2015/05/20ã¡ãã£ã¢: åè¡æ¬ï¼ã½ããã«ãã¼ï¼ãã®ååãå«ãããã°ãè¦ãé«å¦æ´ã¯ã¼ãã³ã°ã㢠ãããªã¼ã¿ã¼çç£å·¥å ´ãã¨ãã¦ã®å¤§å¦é¢ (å æ社æ°æ¸) ä½è : æ°´ææéåºç社/ã¡ã¼ã«ã¼: å æ社çºå£²æ¥: 2007/10/16ã¡ãã£ã¢: æ°æ¸è³¼å ¥: 9人 ã¯ãªãã¯: 324åãã®ååãå«ãããã° (231件) ãè¦ã æ¥æ¬å¤©æå¦ä¼ã«ã¯ TENNET ã¨ããã¡ã¼ãªã³ã°ãªã¹ããããããã®å 容ã¯å ¬éããã¦ãã¾ããããã«æµããæ å ±ã®æ°å²ã¯å ¬åæ å ±ãªã®ã§ãéå»ãã°ãæ¼ãã¨ãã¹ãã¯
Not your computer? Use a private browsing window to sign in. Learn more about using Guest mode
6å¹´ã»ã©éãããé¢æ±ãé¢ããããã9å¹´ã¶ãã«é¢è¥¿ã«æ»ã£ã¦ãã¾ããã3æãã£ã±ãã§åè·ãè¾ãã¦ãå¿æ©ä¸è»¢æ°ããä½å± ãæ°ããè·å ´ã§åã¹ã¿ã¼ãããããã§ããé¢è¥¿ã«æ»ã£ã¦ããã¨ãã£ã¦ãã¯ããã¦ä½ãçºãªã®ã§ãå ¨ãæ°ãã人çãæ©ããããªæ°åã§ããå¼ã£è¶ãç´å¾ã¯æ¡ãæºéã ã£ãã®ã§ãæ°å ¥çãæ°ç¤¾ä¼äººã®ããã«æ°é®®ãªæ°æã¡ã§æ°ããçæ´»ãã¯ããã¦ãã¾ãã ãã¦ãé¢æ±ã§ã®æå¾ã®ä»äºã¨ãã¦ã¨ããå¦ä¼ã®ä¼å ±ä½ãï¼ç·¨éä½æ¥ï¼ã«å¾äºãã¾ããããã®ä¼å ±ã®ä¸ã§ãä»å¹´ã®1æã«è¡ã£ãã·ã³ãã¸ã¦ã ãçæ å¦è ã®ç 究çå¦ãã®å 容ãç¹éè¨äºã¨ãã¦ã¾ã¨ãã¾ãããã·ã³ãã¸ã¦ã ã®è¬æ¼è ãä¸æ¹ã«å稿ãå·çãã¦ããã ããå ãã¦ç¾å¨çå¦ä¸ã®æ¹ã ã«ãå¯ç¨¿ãã¦ããã ãã¾ãããåè¨7åã®ç 究çå¦ä½é¨è¨ãèªãããããªå½¢ã«ããã¨ããããã§ãã çæ å¦åéã«éãããããããç 究çå¦ãèãã¦ãã人ããã¤ãã¯ãããã¨æã£ã¦ãã人ãªã©ã®è¯ãæå¼ãã«ãªãã®ã§ã¯ãªããã¨
ç¡è·ã®å士ã®åã«ç¾ããç½è¡£ãçãè人ãè人ã¯ä»äººãªãã¬å°ä»»ã®ããã§ãå士ãå©ããããã«æãããã®ã¹ãããã®çµæ«ãããã«ï¼ æ¬æ ä¸ ææ¥ã®æ¥æ®ã§ãã ã¨ãã大å¦ã®è¥¿ã®éã®ä¸ã«ãã¼ããã空ãä»°ãã§ãããä¸äººã®è¥è ãããã¾ããã è¥è ã¯ç¡è·ã®å士ã¨ãã£ã¦ãå ã¯ãã£ããã¨ãã大å¦é¢ã§å¦ä½ãã¨ã£ããã®ã§ããããå¦ä½åå¾å¾ãè·ã¯ãªãã奨å¦éã¨ããåã®åéãã®ãããããä»ã¯ãã®æ¥ã®æ®ãã«ãå°ãä½ãããããªèº«åã«ãªã£ã¦ããã®ã§ãã ãæ¥ã¯æ®ããããè ¹ã¯æ¸ããããã®ä¸ããã©ãã¸è¡ã£ã¦ããéã£ã¦ãããæã¯ãªãããã ãââãããªæãããã¦çãã¦ããä½ãªãããã£ãèµ°ã£ã¦ããé»è»ã¸ã§ã身ãæãã¦ãæ»ãã§ãã¾ã£ãæ¹ãã¾ãããç¥ããªãã å士ã¯ã²ã¨ããã£ãããããããªåãã¨ãããªããã¨ãæãããããã¦ããã®ã§ãã ããã¨ã©ããããã£ã¦æ¥ãããçªç¶å½¼ã®åã¸è¶³ãæ¢ãããç½è¡£ãçãè人ãããã¾ãããããå¤æ¥ã®å ãæµ´ã³ã¦ã大
ã©ã³ãã³ã°
ã©ã³ãã³ã°
é害
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}